Source: Stemagen
Date: March 5, 2007
Summary:
Stemagen announced today it has acquired the exclusive rights to a patent for a groundbreaking technique that allows the development of embryonic stem cells appearing to have a markedly enhanced potential for therapeutic use -- uniparental embryonic stem cells. Because these extraordinary stem cells are created without fertilization they may represent an acceptable alternative for those who oppose the traditional method that requires the use of embryos that are potentially capable of reproduction.
